Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Anagrelide Hydrochloride

EU orphan designation number: EU/3/00/010   
Active ingredient: Anagrelide Hydrochloride
Indication: Treatment of essential thrombocythaemia
Sponsor: Shire Pharmaceutical Development Limited
Hampshire International Business Park, Chineham, Basingstoke, Hampshire RG24 8EP, United Kingdom
EU Centralised marketing authorisation: A centralised EU marketing authorisation has been obtained under the name Xagrid on 16/11/2004 with the number EU/1/04/295

   Public summary of scientific opinion     EPAR

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
30/01/2001 Centralised Orphan - Designation EMEA/OD/013/00 (2000)4257 of 29/12/2000
20/12/2001 Centralised Orphan - Transfer of orphan designation EMEA/OD/013/00/T/01 (2001)4247 of 14/12/2001